These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10587877)
1. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA]. Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877 [TBL] [Abstract][Full Text] [Related]
2. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)]. Tabata M; Shimizu M; Araake M; Ogawa H Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397 [TBL] [Abstract][Full Text] [Related]
4. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000). Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin. Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753 [TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA]. Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469 [TBL] [Abstract][Full Text] [Related]
9. [Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci]. Tsuchizaki N; Ishikawa J; Hotta K Jpn J Antibiot; 2000 Jun; 53(6):422-9. PubMed ID: 10955238 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus. Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077 [TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320 [TBL] [Abstract][Full Text] [Related]
13. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group]. Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193 [TBL] [Abstract][Full Text] [Related]
14. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus]. Kondo S Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of the genes encoding aminoglycoside-modifying enzymes and methicillin resistance among clinical isolates of Staphylococcus aureus in Tehran, Iran. Yadegar A; Sattari M; Mozafari NA; Goudarzi GR Microb Drug Resist; 2009 Jun; 15(2):109-13. PubMed ID: 19496674 [TBL] [Abstract][Full Text] [Related]
16. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes. Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673 [TBL] [Abstract][Full Text] [Related]
17. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. Ida T; Okamoto R; Shimauchi C; Okubo T; Kuga A; Inoue M J Clin Microbiol; 2001 Sep; 39(9):3115-21. PubMed ID: 11526138 [TBL] [Abstract][Full Text] [Related]
18. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA]. Ishii T; Takayama Y; Takase Y; Orikasa Y Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173 [TBL] [Abstract][Full Text] [Related]
19. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus. Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109 [TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Aoki Y Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]